Janssen to Highlight Latest Scientific Advances in Hematologic Diseases at ASH 2022 with Clinical and Real-World Data Across Innovative Pipeline and Distinguished Portfolio
RARITAN, N.J., November 3, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson are committed to redefining treatment outcomes in the hematology setting and today announced that abstracts from more than 50 company-sponsored studies, plus more than 20 investigator-initiated studies, will be presented at the American Society of Hematology (ASH) Annual Meeting in New Orleans from December 10-13, 2022. Janssen’s commitment to advancing an innovative portfolio of therapies for healthcare professionals and patients is evidenced through more than 70 presentations that span clinical studies and r...
Source: Johnson and Johnson - November 3, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
CAR T Therapy: From Cancer To Autoimmune Disease, The Lupus Example
CAR T cell therapy successfully induced remissions for five lupus patients, according to a recent study. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 1, 2022 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news
SLE Risk in Patients With Immune Thrombocytopenia SLE Risk in Patients With Immune Thrombocytopenia
Which patients with immune thrombocytopenia may be more likely to develop systemic lupus erythematosus? A new study identifies potential risk factors.Arthritis Research & Therapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 1, 2022 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news
Skin Bacteria May Trigger Lupus: Mouse Study
(Source: The Scientist)
Source: The Scientist - October 28, 2022 Category: Science Tags: News & Opinion Source Type: news
Systemic Lupus Erythematosus: Advice for Younger Clinicians Systemic Lupus Erythematosus: Advice for Younger Clinicians
Richard Furie, MD, implores early-career rheumatologists to"respect lupus."Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 19, 2022 Category: Consumer Health News Tags: Rheumatology MDAngle Source Type: news
Systemic Lupus Erythematosus: Unraveling the Immune System Systemic Lupus Erythematosus: Unraveling the Immune System
Richard Furie, MD, reviews the current treatments for systemic lupus erythematosus.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 19, 2022 Category: Consumer Health News Tags: Rheumatology MDAngle Source Type: news
Results of Novel Clinical Study of Guselkumab and Golimumab Combination Therapy Show Adults with Moderately to Severely Active Ulcerative Colitis Maintained Higher Rates of Clinical, Histologic, and Endoscopic Remission at Week 38
SPRING HOUSE, PENNSYLVANIA, October 10, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from an ongoing analysis of a Phase 2a clinical trial showing adults with moderately to severely active ulcerative colitis (UC) who received 12 weeks of combination induction therapy with guselkumab and golimumab, followed by a transition to guselkumab alone for maintenance, achieved a clinical remission ratea (based on the modified Mayo score [mMayo])b at week 38 of 47.9 percent, a higher rate than induction and maintenance treatment with either guselkumab alone (31.0 percent) or golimumab al...
Source: Johnson and Johnson - October 10, 2022 Category: Pharmaceuticals Source Type: news
From Lymphoma To Lupus And Beyond: The Remarkable Research Of CAR T Therapy
The first installment in a series that will explain a recent and revolutionary cell therapy called CAR T, delving into current successes and future opportunities. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 3, 2022 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news
Sleep Deprivation May Increase Risk for Systemic Lupus in Women
Additive interactions between low sleep duration and depression or bodily pain may contribute to risk for systemic lupus erythematosus (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - September 22, 2022 Category: Psychiatry Tags: Family Medicine, Internal Medicine, Neurology, Psychiatry, Rheumatology, Anesthesiology & amp; Pain, Journal, Source Type: news
Sleep Deprivation May Increase Risk for Systemic Lupus in Women
THURSDAY, Sept. 22, 2022 -- Lack of sleep is associated with an increased risk for systemic lupus erythematosus (SLE), particularly among women with concomitant depression or bodily pain, according to a study published online Sept. 12 in Arthritis... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 22, 2022 Category: Pharmaceuticals Source Type: news
Cell-Killing Cancer Therapy Treats Lupus Successfully Cell-Killing Cancer Therapy Treats Lupus Successfully
' Our data reveal unexpected insights for a role of CAR T cells in nonmalignant diseases that could provide new opportunities for the treatment of autoimmune disease, ' the study authors write.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 22, 2022 Category: Cancer & Oncology Tags: Rheumatology News Source Type: news
The Disparity of Outcomes in Persons of Color Living With Systemic Lupus Erythematosus The Disparity of Outcomes in Persons of Color Living With Systemic Lupus Erythematosus
Michelle Petri, MD, discusses the more frequent and worse kidney outcomes in African American and Hispanic American individuals living with systemic lupus erythematosus (SLE).Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 21, 2022 Category: Consumer Health News Tags: Rheumatology MDAngle Source Type: news
Treatment of Systemic Lupus Erythematosus: An Appreciation of Mentorship Treatment of Systemic Lupus Erythematosus: An Appreciation of Mentorship
Michelle Petri, MD, recalls lessons learned from a respected mentor.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 21, 2022 Category: Consumer Health News Tags: Rheumatology MDAngle Source Type: news
In Small Study, CAR-T Therapy Pushes Lupus Into Remission
While there's no cure for lupus and treatments don't work for everyone with the disease, a new study shows a cancer therapy may kick hard-to-treat lupus into remission. (Source: WebMD Health)
Source: WebMD Health - September 15, 2022 Category: Consumer Health News Source Type: news
In Small Study, CAR-T Therapy Pushes Lupus Into Remission
THURSDAY, Sept. 15, 2022 -- While there’s no cure for lupus and treatments don’t work for many of the 1.5 million people who live with the disease in the United States, a new study shows a cancer therapy may kick hard-to-treat lupus into... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 15, 2022 Category: General Medicine Source Type: news
